Wiesner Rh
About
In The Last Decade
Wiesner Rh
17 papers receiving 308 citations
Peers
Comparison fields: 5 of 42
- Hepatology 202
- Epidemiology 154
- Surgery 148
- Transplantation 90
- Pulmonary and Respiratory Medicine 44
Countries citing papers authored by Wiesner Rh
This map shows the geographic impact of Wiesner Rh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiesner Rh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiesner Rh more than expected).
Fields of papers citing papers by Wiesner Rh
This network shows the impact of papers produced by Wiesner Rh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiesner Rh. The network helps show where Wiesner Rh may publish in the future.
Co-authorship network of co-authors of Wiesner Rh
This figure shows the co-authorship network connecting the top 25 collaborators of Wiesner Rh. A scholar is included among the top collaborators of Wiesner Rh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiesner Rh. Wiesner Rh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 2 | |
| 3 | Twelve years of liver transplantation at the Mayo Clinic. | 6 |
| 4 | Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. | 53 |
| 5 | Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. | 20 |
| 6 | 4 | |
| 7 | Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. | 7 |
| 8 | Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. | 8 |
| 9 | Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. | 19 |
| 10 | Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis. | 5 |
| 11 | Selective bowel decontamination for infection prophylaxis in liver transplantation patients. | 10 |
| 12 | A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. | 35 |
| 13 | The syndrome of primary sclerosing cholangitis. | 39 |
| 14 | Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. | 33 |
| 15 | Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. | 48 |
| 16 | Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: a rejection indicator. | 3 |
| 17 | A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.